Third party funded individual grant (15.01.2024 – 15.01.2027)
Third Party Funds Group - Sub project (01.01.2024 – 01.01.2027)
Part of SFB 1607: Neue immunmodulierende und anti(lymph)angiogene Therapien für altersassoziierte, zur Erblindung führende Augenerkrankungen
Third Party Funds Group - Sub project (01.01.2024 – 01.01.2027)
Part of SFB 1607: Neue immunmodulierende und anti(lymph)angiogene Therapien für altersassoziierte, zur Erblindung führende Augenerkrankungen
Internally funded project (01.01.2024 – 01.01.2027)
Third Party Funds Group - Overall project (01.01.2024 – 01.01.2027)
Third party funded individual grant (29.11.2021 – 31.12.2026)
Third party funded individual grant (01.07.2024 – 31.12.2026)
Third Party Funds Group - Sub project (01.01.2024 – 31.12.2026)
Part of Internet of Bio-Nano-Things
Third party funded individual grant (01.01.2024 – 31.12.2026)
Third Party Funds Group - Sub project (01.01.2024 – 31.12.2026)
Part of FOSTERING THE EUROPEAN ENERGY TRANSITION WITH EXASCALE